Sweden· SE-20091219000022
Brevibloc 10 mg/ml Infusionsvätska, lösning
A medicinal product containing esmolol hydrochloride, registered in Sweden by Baxter Medical AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Esmolol Hydrochloride
- Manufacturer
- Baxter Medical AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20091219000022
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Esmolol hydrochloride in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesesmolol hydrochlorideSagent Pharmaceuticals
- FinlandBreviblocBaxter Oy
- SpainBREVIBLOC 10 mg/ml SOLUCION PARA PERFUSIONBaxter S.L.
- IrelandBrevibloc Premixed 10 mg/ml solution for InfusionBaxter Holding B.V.
- BelgiumBrevibloc 10 mg/mlBaxter
- NorwayBreviblocBaxter Medical AB
- SwitzerlandBrevibloc 2,5 g/250 ml, InfusionslösungBaxter AG
- United KingdomBrevibloc Concentrate 2.5g/10ml solution for infusion ampoulesBaxter Healthcare Ltd
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Brevibloc, Esmolol Amomed
- Belgium · Brevibloc
- Cyprus · Brevibloc, Esmobeta
- Czechia · Esmocard, Esmocard Lyo
- Germany · Brevibloc, Esmocard
- Denmark · Brevibloc
- Spain · Brevibloc, Esmolol Aurovitas
- Finland · Brevibloc
- France · Brevibloc, Esmocard
- United Kingdom (Northern Ireland) · Brevibloc Premixed, Esmolol Hikma Farmacêutica (Portugal)
- Greece · Brevibloc, Esmobeta
- Croatia · Esmocard
- Ireland · Brevibloc Premixed
- Italy · Brevibloc, Esmocard
- Luxembourg · Brevibloc
- Malta · Brevibloc Premixed
- Netherlands · Brevibloc, Esmolol Hcl Hikma
- Norway · Brevibloc
- Portugal · Brevibloc, Esmolol Eugia
- Slovenia · Esmocard, Esmocard Lyo
- Slovakia · Esmocard, Esmocard Lyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa072d75-94d2-4969-8b6a-8d3cc74034c1 GET /v1/drugs/fa072d75-94d2-4969-8b6a-8d3cc74034c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20091219000022",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20091219000022",
"product_doc_link": "https://docetp.mpa.se/LMF/Brevibloc%2010%20mg%20per%20ml%20solution%20for%20infusion%20SmPC_09001bee807a1e41.pdf"
}See everything about esmolol hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.